查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1542793

医药级氯化钠的全球市场

Pharmaceutical Grade Sodium Chloride
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 102 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

至2030年，全球医药级氯化钠市场预计将达到9.737亿美元

2023 年全球医药级氯化钠市场预计为 6.648 亿美元，预计到 2030 年将达到 9.737 亿美元，2023-2030 年分析期间复合年增长率为 5.6%。透析最终用途是本报告分析的细分市场之一，预计复合年增长率为 6.0%，到分析期结束时将达到 4.175 亿美元。分析期内，注射最终用途产业的复合年增长率预计为 6.3%。

美国市场预估为1.793亿美元，中国预期复合年增长率为5.1%

预计2023年美国医药级氯化钠市场规模为1.793亿美元。中国作为全球第二大经济体，预计2030年市场规模将达1.515亿美元，2023年至2030年复合年增长率为5.1%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.8% 和 4.6%。在欧洲，德国的复合年增长率预计为 4.2%。

全球医药级氯化钠市场－主要趋势与驱动因素总结

确保纯度：医药级氯化钠的关键作用

药用级氯化钠，俗称食盐，是用于医疗和製药目的的高精製氯化钠。与普通食盐不同，此等级的氯化钠不含污染物和杂质，可确保敏感应用的安全性和有效性。氯化钠在多种药物製剂中发挥重要作用，包括静脉生理食盐水、口服补液盐和注射稀释剂。医药级氯化钠的纯度和一致性对于确保医药产品符合严格的监管标准并提供有效的治疗至关重要。其应用范围从透析液、创伤护理产品，甚至鼻腔清洗，凸显了其在现代医疗保健中的多功能性和不可或缺性。

技术进步如何提高药用氯化钠的品质？

科技的进步大大提高了医药级氯化钠的生产和品管。先进的结晶和薄膜过滤等精製技术，增强了杂质的去除，确保氯化钠的高纯度，符合世界各地药典的严格标准。引进高效液相层析（HPLC）和原子吸收光谱（AAS）等先进分析方法，能准确监测杂质含量，确保一致性和安全性。此外，製造过程的自动化可以最大限度地减少人为错误并提高生产效率。这些技术进步不仅确保了药用氯化钠的高品质，而且能够实现大规模生产，以满足医疗保健领域不断增长的需求。

药用氯化钠有哪些法规和安全标准？

医药级氯化钠遵循严格的监管和安全标准，以确保其适合医疗用途。美国食品药物管理局(FDA) 和欧洲药品管理局 (EMA) 等监管机构对这项重要成分的製造、测试和标籤制定了严格的指导方针。必须遵守美国药典 (USP) 和欧洲药典 (Ph.Eur.) 等药典标准。这些标准规定了可接受的杂质水平、微生物极限以及所需的物理和化学特性。製造商还必须遵守良好生产规范 (GMP)，其中包括品管系统、卫生标准和文件程序。遵守这些严格的规定可确保医药级氯化钠在医疗应用中安全使用并符合最高品质标准。

推动医药级氯化钠市场成长的因素有哪些？

医药级氯化钠市场的成长受到多种因素的推动。首先，糖尿病和肾臟病等慢性疾病的增加增加了对静脉注射生理食盐水和透析治疗的需求，而这需要高纯度的氯化钠。精製和製造流程的技术进步正在提高产品品质并扩大生产能力，以满足不断增长的医疗保健需求。此外，世界人口的老化正在增加对使用药用级氯化钠的各种治疗的需求。生物製药行业的扩张需要高品质的药物配方和生产原材料，这进一步推动了市场的成长。此外，严格的监管标准使製造商能够持续改进其生产流程和品管，以确保安全有效地供应医药级氯化钠。最后，对个人化医疗和先进给药系统的日益关注正在为药用氯化钠的特殊用途创造新的机会，刺激市场扩张。

受访企业范例（12家知名企业）

  • Akzo Nobel NV
  • Dominion Salt Ltd.
  • Hebei Huachen Pharmaceutical Co., Ltd.
  • K+S France SAS
  • Morton Salt, Inc.
  • Salinen Austria Aktiengesellschaft
  • Sudwestdeutsche Salzwerke AG
  • Swiss Saltworks
  • Tianjin Changlu Haijing Group Co., Ltd.
  • US Salt, LLC.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP13957

Global Pharmaceutical Grade Sodium Chloride Market to Reach US$973.7 Million by 2030

The global market for Pharmaceutical Grade Sodium Chloride estimated at US$664.8 Million in the year 2023, is expected to reach US$973.7 Million by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Dialysis End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$417.5 Million by the end of the analysis period. Growth in the Injections End-Use segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$179.3 Million While China is Forecast to Grow at 5.1% CAGR

The Pharmaceutical Grade Sodium Chloride market in the U.S. is estimated at US$179.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$151.5 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Pharmaceutical Grade Sodium Chloride Market - Key Trends and Drivers Summarized

Ensuring Purity: The Essential Role of Pharmaceutical Grade Sodium Chloride

Pharmaceutical grade sodium chloride, commonly known as salt, is a highly purified form of sodium chloride used in medical and pharmaceutical applications. Unlike regular table salt, this grade of sodium chloride is free from contaminants and impurities, ensuring its safety and efficacy in sensitive applications. It plays a critical role in various pharmaceutical formulations, including intravenous (IV) saline solutions, oral rehydration salts, and as a diluent for injectable drugs. The purity and consistency of pharmaceutical grade sodium chloride are paramount as they ensure that medications meet stringent regulatory standards and provide effective treatment. Its use extends to dialysis solutions, wound care products, and even as a nasal rinse, highlighting its versatility and indispensability in modern healthcare.

How Are Technological Advancements Enhancing the Quality of Pharmaceutical Sodium Chloride?

Technological advancements have significantly improved the production and quality control of pharmaceutical grade sodium chloride. Advanced purification techniques, such as recrystallization and membrane filtration, have enhanced the removal of impurities, ensuring high-purity sodium chloride that meets the stringent standards of pharmacopeias worldwide. The implementation of sophisticated analytical methods, including high-performance liquid chromatography (HPLC) and atomic absorption spectroscopy (AAS), allows for precise monitoring of impurity levels, ensuring consistency and safety. Furthermore, automation in manufacturing processes has minimized human error and increased production efficiency. These technological strides not only ensure the high quality of pharmaceutical sodium chloride but also enable large-scale production to meet the growing demand in the healthcare sector.

What Are the Regulatory and Safety Standards Governing Pharmaceutical Sodium Chloride?

Pharmaceutical grade sodium chloride is subject to rigorous regulatory and safety standards to ensure its suitability for medical use. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose strict guidelines on the production, testing, and labeling of this critical ingredient. Compliance with pharmacopeial standards, such as the United States Pharmacopeia (USP) and the European Pharmacopoeia (Ph. Eur.), is mandatory. These standards specify the acceptable levels of impurities, microbial limits, and the required physical and chemical properties. Manufacturers must also adhere to Good Manufacturing Practices (GMP), which encompass quality management systems, hygiene standards, and documentation procedures. The adherence to these stringent regulations ensures that pharmaceutical grade sodium chloride is safe for use in medical applications and meets the highest quality standards.

What Factors Are Driving Growth in the Pharmaceutical Grade Sodium Chloride Market?

The growth in the pharmaceutical grade sodium chloride market is driven by several factors. Firstly, the increasing prevalence of chronic diseases such as diabetes and kidney disorders is boosting the demand for IV saline solutions and dialysis treatments, where high-purity sodium chloride is essential. Technological advancements in purification and manufacturing processes are enhancing product quality and expanding production capacity, meeting the rising healthcare needs. Additionally, the aging global population is contributing to higher demand for various medical treatments that utilize pharmaceutical grade sodium chloride. The expansion of the biopharmaceutical sector, which requires high-quality raw materials for drug formulation and production, is further propelling market growth. Furthermore, stringent regulatory standards are driving manufacturers to continuously improve their production processes and quality controls, ensuring the supply of safe and effective pharmaceutical grade sodium chloride. Lastly, the increasing focus on personalized medicine and advanced drug delivery systems is creating new opportunities for specialized applications of pharmaceutical sodium chloride, fueling market expansion.

Select Competitors (Total 12 Featured) -

  • Akzo Nobel NV
  • Dominion Salt Ltd.
  • Hebei Huachen Pharmaceutical Co., Ltd.
  • K+S France S.A.S.
  • Morton Salt, Inc.
  • Salinen Austria Aktiengesellschaft
  • Sudwestdeutsche Salzwerke AG
  • Swiss Saltworks
  • Tianjin Changlu Haijing Group Co., Ltd.
  • US Salt, LLC.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Pharmaceutical Grade Sodium Chloride - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Injectable Drugs Drives Market Growth
    • Rising Use of Sodium Chloride in Dialysis Solutions Expands Market Opportunity
    • Growth in IV Fluid Market Propels Demand for Pharmaceutical Grade Sodium Chloride
    • Advances in Purification Technologies Enhance Product Quality
    • Increasing Investment in Healthcare Infrastructure
    • Development of Biopharmaceuticals and Biosimilars
    • Expansion of Global Pharmaceutical Manufacturing
    • Rising Focus on Drug Formulation and Stability
    • Growth in Clinical Research and Trials
    • Increasing Applications in Oral Rehydration Solutions
    • Advances in Drug Delivery Systems Impacting Sodium Chloride Usage
    • Growth in Emerging Markets Expands Addressable Market Opportunity
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Pharmaceutical Grade Sodium Chloride by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Dialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Oral Rehydration Salts (ORS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Oral Rehydration Salts (ORS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Oral Rehydration Salts (ORS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Pharmaceutical Grade Sodium Chloride Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Canada 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Japan 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: China 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Pharmaceutical Grade Sodium Chloride by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: France 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Germany 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Italy 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: UK 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 53: Rest of World Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of World Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of World 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION